Maternal Cancer During Pregnancy Linked to Stillbirth, Neonatal Mortality

Share this content:
Although rare, maternal cancer during pregnancy is associated with elevates risks of stillbirth and neonatal death.
Although rare, maternal cancer during pregnancy is associated with elevates risks of stillbirth and neonatal death.

Although rare, maternal cancer during pregnancy is associated with elevated risks of stillbirth and neonatal death, according to a study published in the Journal of Clinical Oncology.1

Limited data are available on the risks of fatal outcomes like stillbirth and infant mortality in pregnancies complicated with cancer. For this study, investigators evaluated whether maternal cancer is associated with increased risks of these outcomes.

The researchers analyzed data from 3,947,215 singleton births in Sweden that occurred between 1973 and 2012. The investigators identified 984 births by women diagnosed with maternal cancer during pregnancy and 2723 births by women diagnosed with maternal cancer during the year after pregnancy.

Maternal cancer diagnosed during pregnancy was associated with an increased risk of stillbirth (incidence rate ratio [IRR], 2.5; 95% CI, 1.2-5.0). This association was confined to stillbirths where the fetus was assessed as small-for-gestational-age (SGA) at birth (IRR, 4.9; 95% CI, 2.2-11.0). Maternal cancer diagnosed during pregnancy was associated with 3-fold higher risk of preterm SGA births (relative risk, 3.0; 95% CI, 2.1-4.4).

Maternal cancer diagnosed during pregnancy or the year after pregnancy were associated with elevated risks for neonatal mortality (deaths within 0 to 27 days; IRR, 2.7; 95% CI, 1.3-5.6 and IRR, 2.0; 95% CI, 1.2-3.2, respectively) and preterm birth (IRR, 5.8; 95% CI, 5.3-6.5 and IRR, 1.6; 95% CI, 1.4-1.8, respectively).

RELATED: Niraparib Expanded Access Program Opened for Women With Ovarian Cancer

Preterm birth was responsible for 89% of the association between maternal cancer during pregnancy and neonatal mortality.

The findings reinforce the need for careful monitoring of fetal growth and cautious decision-making regarding preterm delivery in this population.

Reference

  1. Lu D, Ludvigsson JF, Smedby KE, et al. Maternal cancer during pregnancy and risks of stillbirth and infant mortality. J Clin Oncol. 2017 March 6. doi: 10.1200/JCO.2016.69.9439 [Epub ahead of print]

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters